Search
Clinical Trial
A Phase 3, Randomized Study to Compare Nemtabrutinib Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in Participants With Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BELLWAVE-011)
… Leukemia/Small Lymphocytic Lymphoma (BELLWAVE-011) III Cortese, Matthew J The goal of this study is to evaluate nemtabrutinib …
News
Tandem 2025: Roswell Park Team Creates Predictive Model to Inform Care of Lymphoma Patients
… Adults undergoing Stem cell transplantation) Consortium.” Matthew Cortese, MD, MPH , Assistant Professor of Oncology, …
Tumor Immunology & Immunotherapy Program Members
… Director, Neuro-Oncology Lab Department of Neurosurgery Matthew Cortese, MD, MPH Assistant Professor of Oncology Department …
Roswell Park Scott Bieler Amherst Center
… Bio Reference Gurkamal Chatta, MD Medical Oncology Matthew Cortese, MD, MPH Medical Oncology and Hematology …
News
Roswell Park Experts to Showcase Groundbreaking Hematology Research at 66th ASH Annual Meeting
… oral abstracts On Saturday, Dec. 7, at 10:45 a.m., Matthew Cortese, MD, MPH , will present abstract 78, Multiomic …
Roswell Park at American Society of Clinical Oncology 2025
… Oncology Yeong “Christopher” Choi, PhD, MBA Immunology Matthew Cortese, MD, MPH Medical Oncology and Hematology Marco …
Updates in Hematologic Malignancies and Related Supportive Care
… Speakers Renier Brentjens, MD, PhD Hematologic Oncology Matthew Cortese, MD, MPH Medical Oncology and Hematology Marco …
Page with Layout
CAR T-Cell Therapy
Blog Post
Roswell Park-invented software speeds cancer research
… clinical trials or doing outcomes research,” says Matthew Cortese, MD, MPH , Assistant Professor of Oncology in …
Education
Trainees' Accomplishments and Highlights
… Kristopher Attwood, Francisco J. Hernandez-Ilizaliturri, Matthew J Cortese; Treatment Selection and Clinical Outcomes in …